Published Study Using Our Technology
The attached link is a publication for treating osteoarthritis with stromal cells from fat. This study is utilizing the Macquarie Stem Cells cells method of cell separation.
CLINICAL TRIALS – CURRENTLY RUNNING
- Chronic Migraines – Full Description Below
CLINICAL TRIALS – PENDING
Please click on the conditions listed below to read further.
Dr. Bright is the principal investigator of a clinical trial to study the safety and effectiveness of stromal vascular fraction (SVF) and is actively recruiting participants to the trial.
The trial is titled: A randomised, placebo-controlled, double-blind, proof of concept study of the safety and efficacy of autologous stromal vascular fraction (SVF) cells, in patients with moderate to severe chronic migraine headache.
Do you suffer from chronic migraine?
Macquarie Stem Cells, Professor Roy Beran and Cell-Innovations are currently recruiting for clinical studies on the safety and effectiveness of stem cells in reducing the frequency and severity of chronic migraines. The study is over 12 months. To be considered for study participation you must have chronic migraine and be relatively healthy.
Patient applications are open – for further information to become an applicant you will need to read the suitability criteria.
(click on the trial link below)
Study procedure and care will be provided at no cost. For more information about the potential benefits and risks of the study please contact the trial coordinator at
email@example.com or phone 1300 738 025
This study has been approved by the Northern Sydney Local Health District Human Research Ethics Committee, reference number: HREC/15/HAWKE/279.
The trial has been registered with the Australia and New Zealand Clinical Trials Registry (trial ID ACTRN12615001260516), and the